Inspire Medical Systems, Inc. Share Price

Equities

INSP

US4577301090

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:02 27/04/2024 am IST 5-day change 1st Jan Change
237.4 USD +2.79% Intraday chart for Inspire Medical Systems, Inc. +3.59% +16.72%
Sales 2024 * 782M 65.21B Sales 2025 * 950M 79.24B Capitalization 7.19B 600B
Net income 2024 * -9M -750M Net income 2025 * 24M 2B EV / Sales 2024 * 8.49 x
Net cash position 2024 * 550M 45.88B Net cash position 2025 * 656M 54.67B EV / Sales 2025 * 6.88 x
P/E ratio 2024 *
-603 x
P/E ratio 2025 *
308 x
Employees 1,011
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.09%
More Fundamentals * Assessed data
Dynamic Chart
RBC Initiates Inspire Medical Systems at Outperform With $285 Price Target MT
Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing MT
Wall St set for higher open on megacaps boost; earnings, Fed comments on tap RE
Inspire Medical Systems Insider Sold Shares Worth $8,203,581, According to a Recent SEC Filing MT
Morgan Stanley Initiates Inspire Medical Systems at Overweight Rating With $250 Price Target MT
Transcript : Inspire Medical Systems, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 10:30 AM
UBS Adjusts Inspire Medical Systems Price Target to $265 From $220, Maintains Buy Rating MT
Mizuho Adjusts Price Target on Inspire Medical Systems to $250 From $225, Maintains Buy Rating MT
Inspire Medical Systems Q4 Net Income, Revenue Rise; Reaffirms 2024 Revenue Outlook MT
Transcript : Inspire Medical Systems, Inc., Q4 2023 Earnings Call, Feb 06, 2024
Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS Reports Q4 Revenue $192.5M, vs. Street Est of $191.2M MT
Inspire Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Inspire Medical Systems, Inc. Reaffirms Revenue Guidance for the Full Year 2024 CI
Inspire Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Inspire Medical Systems Names CEO Timothy P. Herbert as Board Chair MT
More news
1 day+2.79%
1 week+3.59%
Current month+10.55%
1 month+14.01%
3 months+11.58%
6 months+58.87%
Current year+16.72%
More quotes
1 week
220.24
Extreme 220.24
244.80
1 month
200.68
Extreme 200.68
250.68
Current year
163.57
Extreme 163.57
250.68
1 year
123.27
Extreme 123.27
330.00
3 years
123.27
Extreme 123.27
330.00
5 years
40.53
Extreme 40.53
330.00
10 years
22.50
Extreme 22.5
330.00
More quotes
Managers TitleAgeSince
Founder 61 01/07/01
Director of Finance/CFO 56 16/14/16
Chief Tech/Sci/R&D Officer 61 28/22/28
Members of the board TitleAgeSince
Director/Board Member 66 25/19/25
Chairman 84 01/16/01
Director/Board Member 79 01/08/01
More insiders
Date Price Change Volume
26/24/26 237.4 +2.79% 604,213
25/24/25 231 -1.36% 229,163
24/24/24 234.2 +0.11% 255,686
23/24/23 233.9 +3.87% 339,016
22/24/22 225.2 -1.75% 591,996

Delayed Quote Nyse, April 27, 2024 at 01:30 am IST

More quotes
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
237.4 USD
Average target price
253.8 USD
Spread / Average Target
+6.88%
Consensus